Congenital immunodeficiencies associated with absence of HLA class II antigens on lymphocytes result from distinct mutations in trans-acting factors
- PMID: 2511169
- DOI: 10.1016/0198-8859(89)90007-4
Congenital immunodeficiencies associated with absence of HLA class II antigens on lymphocytes result from distinct mutations in trans-acting factors
Abstract
Coordinate regulation of HLA class II gene expression during development and coinduction of class II genes by soluble factors suggests that common trans-acting factor(s) control expression of these genes. In B-lymphoblastoid cell lines derived from two independent class II-deficient bare lymphocyte syndrome patients, we observed a drastic decrease in transcription rates of the class II genes. When these cell lines are fused, class II genes are reexpressed, indicating that immunodeficiencies in bare lymphocyte syndrome patients are the result of two distinct mutations. Further studies show that genes governing the expression of class II antigens fall into at least three complementation groups; two of these were previously unidentified in mutant cell lines generated in vitro. In addition, we report the identification of two discrete complexes, NFX1.1 and NFX1.2, that bind to the DRA X consensus element. Though the mutation in at least one mutant line generated in vitro (RJ2.2.5) affects products functioning via interaction with the X box, clear alterations in either NFX1.1 or NFX1.2 are not found in any of the mutant cell lines.
Similar articles
-
Genetic complexity of regulatory mutants defective for HLA class II gene expression.J Immunol. 1992 Mar 1;148(5):1576-84. J Immunol. 1992. PMID: 1538137
-
Functional complementation of major histocompatibility complex class II regulatory mutants by the purified X-box-binding protein RFX.Mol Cell Biol. 1994 Oct;14(10):6839-47. doi: 10.1128/mcb.14.10.6839-6847.1994. Mol Cell Biol. 1994. PMID: 7935401 Free PMC article.
-
Defective HLA DRA X box binding in the class II transactive transcription factor mutant 6.1.6 and in cell lines from class II immunodeficient patients.J Immunol. 1991 Jun 15;146(12):4398-405. J Immunol. 1991. PMID: 1904083
-
Combined immunodeficiency with defective expression in MHC class II genes.Immunodefic Rev. 1989;1(2):135-53. Immunodefic Rev. 1989. PMID: 2517209 Review.
-
Major histocompatibility complex class II deficiency: a clinical review.Blood Rev. 1996 Dec;10(4):242-8. doi: 10.1016/s0268-960x(96)90008-9. Blood Rev. 1996. PMID: 9012922 Review.
Cited by
-
Splicing defect in RFXANK results in a moderate combined immunodeficiency and long-duration clinical course.Immunogenetics. 2003 Nov;55(8):530-9. doi: 10.1007/s00251-003-0609-2. Epub 2003 Oct 22. Immunogenetics. 2003. PMID: 14574520
-
Locus- and allele-specific DNA-protein interactions in the HLA-DQB1 X box.Immunol Res. 1993;12(4):317-29. doi: 10.1007/BF02935505. Immunol Res. 1993. PMID: 8151156
-
Primary T-lymphocyte immunodeficiencies.Clin Rev Allergy Immunol. 2001 Feb;20(1):3-26. doi: 10.1385/CRIAI:20:1:3. Clin Rev Allergy Immunol. 2001. PMID: 11269227 Review. No abstract available.
-
Specific complex formation between the type II bare lymphocyte syndrome-associated transactivators CIITA and RFX5.Proc Natl Acad Sci U S A. 1997 Jun 10;94(12):6330-4. doi: 10.1073/pnas.94.12.6330. Proc Natl Acad Sci U S A. 1997. PMID: 9177217 Free PMC article.
-
NFX1, Its Isoforms and Roles in Biology, Disease and Cancer.Biology (Basel). 2021 Mar 30;10(4):279. doi: 10.3390/biology10040279. Biology (Basel). 2021. PMID: 33808060 Free PMC article. Review.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Molecular Biology Databases
Research Materials